Zoetis, Inc. (ZTS)
72.97
+0.11
(+0.15%)
USD |
NYSE |
Sep 11, 16:00
73.12
+0.15
(+0.21%)
After-Hours: 20:00
Zoetis Price to Book Value : 9.60 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 9.60 |
| September 10, 2026 | 9.586 |
| September 09, 2026 | 9.645 |
| September 08, 2026 | 9.678 |
| September 04, 2026 | 9.974 |
| September 03, 2026 | 10.04 |
| September 02, 2026 | 10.02 |
| September 01, 2026 | 10.16 |
| August 31, 2026 | 10.14 |
| August 28, 2026 | 10.17 |
| August 27, 2026 | 9.870 |
| August 26, 2026 | 10.20 |
| August 25, 2026 | 10.17 |
| August 24, 2026 | 10.15 |
| August 21, 2026 | 10.23 |
| August 20, 2026 | 9.870 |
| August 19, 2026 | 10.09 |
| August 18, 2026 | 9.730 |
| August 17, 2026 | 9.60 |
| August 14, 2026 | 9.708 |
| August 13, 2026 | 9.978 |
| August 12, 2026 | 9.675 |
| August 11, 2026 | 9.913 |
| August 10, 2026 | 9.845 |
| August 07, 2026 | 9.559 |
| Date | Value |
|---|---|
| August 06, 2026 | 10.17 |
| August 05, 2026 | 9.787 |
| August 04, 2026 | 10.00 |
| August 03, 2026 | 10.14 |
| July 31, 2026 | 10.17 |
| July 30, 2026 | 10.00 |
| July 29, 2026 | 10.25 |
| July 28, 2026 | 10.20 |
| July 27, 2026 | 10.12 |
| July 24, 2026 | 9.913 |
| July 23, 2026 | 9.810 |
| July 22, 2026 | 9.760 |
| July 21, 2026 | 9.913 |
| July 20, 2026 | 10.02 |
| July 17, 2026 | 10.07 |
| July 16, 2026 | 10.12 |
| July 15, 2026 | 9.805 |
| July 14, 2026 | 9.745 |
| July 13, 2026 | 9.918 |
| July 10, 2026 | 9.941 |
| July 09, 2026 | 9.878 |
| July 08, 2026 | 9.880 |
| July 07, 2026 | 10.04 |
| July 06, 2026 | 9.922 |
| July 02, 2026 | 9.841 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc. | 1.854 |
| Elanco Animal Health, Inc. | 1.757 |
| Boston Scientific Corp. | 2.494 |
| Eli Lilly & Co. | 31.01 |
| Merck & Co., Inc. | 8.473 |
Price to Book Value Related Metrics
| PE Ratio | 12.00 |
| PS Ratio | 3.301 |
| PEG Ratio | 2.208 |
| Price to Free Cash Flow | 13.28 |
| Price | 72.97 |
| Earnings Yield | 8.33% |
| Market Cap | 30.22B |
| PEGY Ratio | 1.446 |
| Operating PE Ratio | 8.767 |
| Normalized PE Ratio | 11.61 |